Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group
2025 · European Urology · 7 citations
https://doi.org/10.1016/j.eururo.2024.12.018
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.1K
Citations
15
h-index
16
i10-index
Nikos G. Gavalas is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & melanin and skin pigmentation & Angiogenesis and VEGF in Cancer. The author has an h-index of 15, co-authored 29 publications.
Click to start Chat